SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sirna Therapeutics Inc
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
562 31 0 RNAI
Emcee:  advinfo Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
137 Does anyone understand why RZYM has been falling so dramatically in the last feDGMontana-7/7/1998
136 I agree that they (RZYM) has no market currently, but IMHO even if only one of Baker-7/5/1998
135 MM has this marked as a speculative stock. Read his charts on it carefully. As jbershad-7/5/1998
134 Well, MM seems to have upgraded his price target. Several years ago when I bouBaker-6/23/1998
133 i value CTSL's basic research on technology and biotech but i have learned bob zagorin-6/23/1998
132 I also subscribe to CTSL and what do you think of MM's advice? I have boughhoops-6/23/1998
131 as a subscriber, i'll respect their request that inf. not be copied so i subob zagorin-6/23/1998
130 Can you scan it in? Scott Ozer-6/23/1998
129 new issue of CTSL (Mike Murphy) has fairly long update on RZYM. first talks abobob zagorin-6/23/1998
128 TO all; The formation of a German based company to take advantage of new fundiDavid Bogdanoff-6/17/1998
127 I'm particularly impressed the the government (BMBF) will be investing $3.3Baker-6/17/1998
126 check this out. Federal Minister Presents 'Miracle In Germany' at BIO bob zagorin-6/17/1998
125 The 1997 payments from Schering AG were the first in the collaboration which inBaker-6/16/1998
124 oops, I guess they have announced the Shering equity investment. I had not reaThomas-6/16/1998
123 Baker, let's not count chickens here. I concur that this is an intriguing Thomas-6/16/1998
122 Ribozeme continues to amaze me. This demonstrates (at least to me) that this iBaker-6/16/1998
121 Ribozyme Pharmaceuticals, Inc. Announces Creation of a New Target Validation Cobob zagorin-6/16/1998
120 Thomas, Yeah, I still stop by every now and then, but still hold no position. tuck-6/11/1998
119 good call celery, reaction delayed until today but stock is popping on good volbob zagorin-6/9/1998
118 Hi all, I followed RZYM for awhile after their IPO a couple years ago. I feltJohn Dwyer-6/9/1998
117 I find this interesting. As far as I know, Ribozyme has the exclusive rights (Baker-6/8/1998
116 Bob; I read a similar conclusion a month or so ago in Technology Review, the MISteve Lokness-6/8/1998
115 OK, answered my own question. The UCSD clinical trial is led by Immusol, who Thomas-6/8/1998
114 Tuck, you still out there? From an Alta Vista search, I came up with the folloThomas-6/6/1998
113 interesting article in new red herring on why protein research is more importanbob zagorin-6/6/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News